Comparative in vitro evaluation of dithiane analogs of tiapamil, Ro 11-2933, Ro 44-5916 and Ro 44-5912 as multidrug resistance modulators

Anti-Cancer Drugs

Volumn 7, Issue 4, 1996, Pages 430-436

  Abderrabi, Mostafa ^a   Marchai, Sophie ^a   Merlin, Jean Louis ^a  

^a CENTRE ALEXIS VAUTRIN   (France)

Author keywords

Multidrug resistance; Resistance modifiers; Tiapamil analogs; Verapamil

Indexed keywords

1,3 DITHIANE DERIVATIVE; DAUNORUBICIN; DOXORUBICIN; GLYCOPROTEIN P; N (3,4 DIMETHOXYPHENETHYL) N METHYL 2 (2 NAPHTHYL) 1,3 DITHIANE 2 PROPYLAMINE; RO 44 5911; RO 44 5912; TETRAZOLIUM; TIAPAMIL DERIVATIVE; UNCLASSIFIED DRUG; VERAPAMIL;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL STRAIN K 562; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACCUMULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

ADENOCARCINOMA; BREAST NEOPLASMS; CALCIUM CHANNEL BLOCKERS; DAUNORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; FLOW CYTOMETRY; HUMANS; LEUKEMIA, EXPERIMENTAL; PROPYLAMINES; TUMOR CELLS, CULTURED; VERAPAMIL;

EID: 0029979049     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199606000-00009     Document Type: Article

References (33)

1. Ling V. P-glycoprotein and resistance to anticancer drug. Cancer 1992; 69: 2603-9.
2. D'Incalci M, Broxterman HJ, Van Kalken CK. Membrane transport in multidrug resistance, development and disease. Ann Oncol 1991; 2: 635-9.
3. Merlin JL, Missoum N, Marchai S, et al. Double labeling flow cytometry analysis of multidrug resistance in leukemias and lymphomas. In: Kaspers GJL, Pieters R, Twentyman PR, Weisenthal LM, Veerman AJP, eds. Drug resistance in leukemia and lymphoma, Chur, Switzerland: Harwood Academic 1993: 95-103.
4. Van der Bliek AM, Borst P. Multidrug resistance. Adv Cancer Res 1989; 52: 165-203.
5. Endicott JA, Ling V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Ann Rev Biochem 1989; 58: 137-71.
6. Fojo AT, Ueda K, Slamon DJ, et al. Expression of a multidrug resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 1987; 84: 265-9.
7. Ling V, Juliano RT. A surface glycoprotein modulation drug permeability in Chinese hamster ovary cell mutants. Biochem Biophys Acta 1976; 445: 152-62.
8. Pastan I, Gottesman M. Multiple-drug resistance in human cancer. N Engl J Med 1987; 316: 1388-93.
9. Bradley G, Georges E, Ling V. Mechanism of multidrug resistance. Biochim Biophys Acta 1988; 948: 87-128.
10. Moscow JA, Cowan KH. Multidrug resistance. J Natl Cancer Inst 1988; 80: 14-20.
11. Kessel D, Wilberding C. Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists. Cancer Res 1985; 45: 1687-91.
12. Tsuruo T, Ilida H, Tsukagoshi S, et al. Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors. Cancer Res 1982; 42. 4730-3.
13. Mickisch GH, Kossig J, Keilhauer G, et al. Effects of calcium antagonists in multidrug resistant primary human renal cell carcinomas. Cancer Res 1990; 50: 3670-4.
14. Bruno NA, Slate DL. Effect of exposure to calcium entry blockers on doxorubicin accumulation and cytotoxicity in multidrug resistance cells. J Natl Cancer Inst 1990 82: 419-424.
15. Sonneveld P, Nooter K. Reversal of drug resistance by cyclosporin-A in a patient with acute myelocytic leukaemia. Br J Haematol 1990; 75: 208-11.
16. Fleming GF, Amato JM, Agresti M, et al. Megestrol acetate reverses multidrug resistance and interacts with P-glycoprotein. Cancer Chemother Pharmacol 1992; 29: 445-9.
17. Ozols RF, Cunnion RF, Kleker RW, et al. Verapamil and adriamycin in the treatment of drug resistance in ovarian cancer patients. J Clin Oncol 1987; 5: 641-7.
18. Ramuz H, Schmutz W, Huber R. RO 11 -2933, a potential drug in the treatment of cancer and malaria: synthesis and physicochemical propertial metabolites. Eur J Med Chem 1989; 24: 493-6.
19. Kessel D, Wilberding C. Promotion of daunorubicin uptake and toxicity by the calcium antagonist tiapamil and its analogs. Cancer Treat Rep 1985; 69: 673-6.
20. Mazzoni A. In vitro reversal of doxorubicin resistance by the tiapamil analog RO 11-2933 in human ovarian cancer cells. Tumori 1990; 76: 69-79.
21. Alaoui-Jamali M, Schecter RL, Rustum YM, et al. In vivo reversal of doxorubicin resistance by a new tiapamil analog Ro 11-2933. J Pharmacol Exp Ther 1993; 264: 1299-304.
22. Plumb JA, Wishart GC, Setanoians A, et al. Identification of a multidrug resistance modulator with clinical potential by analysis of synergistic activity in vitro, toxicity in vivo and growth delay in a solid human tumour xenograft. Biochem Pharmacol 1994; 47: 257-66.
23. Eliason JF, Ramuz H, Yoshikubo T, et al. Novel diathiane analogues of tiapamil with high activity to overcome multitlrug resistance in vivo Biochem Pharmacol 1995; 50: 187-96.
24. De Jong G, Gelmon G, Bally M, et al. Modulation of doxorubicin resistance in P388/ADR cells by Ro 44-5912, a tiapamil derivative. Anticancer Res 1995; 15: 911-6.
25. Merlin JL, Guerci A, Marchal S, et al. Comparative evaluation of S9788, verapamil and cyclosporine A in K562 human leukemia cell lines and in P-glycoprotein-expressing samples from patients with hematologic malignancies. Blood 1994; 84: 262-9.
26. Chou TC, Talalay P. Quantative analysis of dose-effect relationships: the combined effects of multiple drugs on enzyme inhibitors. Adv Enzyme Regul 1984; 22: 27-55.
27. Huet S, Robert J. The reversal of doxorubicin resistance by verapamil is not clue to an effect on calcium channels. Int J Cancer 1988; 41: 283-6.
28. Yusa K, Tsuruo T. Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ ADM cells. Cancer Res 1989; 49: 5002-6.
29. Cole SPC. Multidrug resistance in small-cell lung cancer. Can J Physiol Pharmacol 1992; 70: 313-29.
30. Eliason JF, Sawada R, Tsukaguchi T, et al. The dithiane Ro 44-5912 enhances vinblastine sensitivity of drug resistant and parental KB lines in vivo. Eur J Cancer 1995; 31A: 13-1.
31. Eliason J, Ramuz H, Kaufmann F. Human tumor cells exhibit a high degree of selectivity for stereoisomers of verapamil and quinidine. Int J Cancer 1990; 46: 113-7.
32. Bennis S, Ichas F, Robert J. Differential effects of verapamil and quinidine on the reversal of doxorubicin resistance in a human leukemia cell line. Int J Cancer 1995; 62: 283-90.
33. Merlin JL, Marchai S, Ramacci C, et al. Influence of S9788, a new modulator of multidrug resistance, on the cellular accumulation and subcellular distribution of daunorubicin in P-glycoprotein-expressing MCF-7 human breast adenocarcinoma cells. Cytometry 1995; 20: 315-23.